跳至主要内容
临床试验/NCT04386551
NCT04386551已完成不适用

Evaluation of the Performance of a Saliva Sample Versus a Nasopharyngeal Sample in the Diagnosis of COVID-19 by RT-PCR

Centre Hospitalier Universitaire, Amiens1 个研究点 分布在 1 个国家目标入组 501 人开始时间: 2020年5月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
501
试验地点
1
主要终点
Detection of SARS-CoV-2 RNA in the saliva sample

研究概览

简要总结

Since December 2019, the world has faced a pandemic of COVID-19, an infectious disease caused by SARS-CoV-2, a virus that emerged in China. The reference diagnosis is based on the search for the SARS-COV-2 genome in the nasopharyngeal sample.

Carrying out this sample requires the competence of a healthcare professional and presents some inconveniences for the tested patient. Because saliva collection is simple, non-invasive, painless and inexpensive, and can be performed by poorly trained personnel, it could be an alternative to the reference nasopharyngeal sample. SARS-CoV2 detection in human saliva could be a potential diagnosis of COVID infection.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patient hospitalized at the Amiens CHU in a COVID-19 unit
  • patient seen as outpatient in the area of infectious pathologies for COVID-19 infection

排除标准

  • Patients under 18
  • patients under guardianship or curators

结局指标

主要结局

Detection of SARS-CoV-2 RNA in the saliva sample

时间窗: day 1

Detection of SARS-CoV-2 RNA in the saliva sample

Concordance between the Saliva sample and the nasonasopharyngeal sample SARS-CoV-2 RT-PCR results

时间窗: day 1

Concordance between the Saliva sample and the nasonasopharyngeal sample SARS-CoV-2 RT-PCR results

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验